{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:37:03Z","timestamp":1787841423502,"version":"build-2784847793"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Colchicine is the fundamental treatment of familial Mediterranean fever (FMF). Still, 5\u201310% of patients are not in remission with colchicine treatment. A consensus could not be established for the definition of colchicine resistance in FMF. This study aimed to determine factors that help to predict colchicine resistance in pediatric FMF patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Patients with FMF that age of diagnosis was under 18 years old were included in our study. Fifty colchicine responsive and 33 colchicine-resistant patients were stratified as groups 1 and 2, respectively. Patients\u2019 clinical and laboratory findings were evaluated. Logistic regression analysis was used to determine the risk factors of colchicine-resistant FMF. Receiver operating characteristic (ROC) curve analysis was used to identify and compare the predictive performances of colchicine-resistant FMF models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Homozygous exon 10 MEFV mutations were frequent in group 2 (Group 1: 34 (68%), group 2: 32 (97%), p\u2009=\u2009.013). Univariate analysis showed that the age of onset of symptoms, age of diagnosis, chronic arthritis, myalgia and diarrhea during attacks, and the number of attacks, high ISSF and Pras score, high C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) values under colchicine treatment were risk factors for colchicine-resistant FMF. With multivariate analysis, the number of attacks (OR 1.418, CI (95%) 1.149\u20131.750, p\u2009=\u2009.001) and high ESR values (OR 1.129, CI (95%) 1.059\u20131.204, p&amp;lt;.001) were detected as independent risk factors for colchicine-resistant FMF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The predictive factors were determined for pediatric colchicine-resistant FMF in our study. The results will help to early diagnosis and treatment of chronic inflammation in FMF.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1080\/14397595.2021.1908502","type":"journal-article","created":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T20:18:25Z","timestamp":1616962705000},"page":"177-185","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["The remarkable characteristics of the children with colchicine-resistant familial Mediterranean fever in Turkey"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2122-6952","authenticated-orcid":false,"given":"Nihal","family":"Sahin","sequence":"first","affiliation":[{"name":"Department of Pediatric Rheumatology, Erciyes University, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3290-4413","authenticated-orcid":false,"given":"Sumeyra","family":"Ozdemir Cicek","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Erciyes University, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1800-9922","authenticated-orcid":false,"given":"Aysenur","family":"Pac Kisaarslan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Erciyes University, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5142-8432","authenticated-orcid":false,"given":"Muammer Hakan","family":"Poyrazoglu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Erciyes University, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1358-7632","authenticated-orcid":false,"given":"Zubeyde","family":"Gunduz","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Kayseri Acibadem Hospital, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0599-7199","authenticated-orcid":false,"given":"Ruhan","family":"Dusunsel","sequence":"additional","affiliation":[{"name":"Department of Pediatric Rheumatology, Erciyes University, Kayseri, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"2022010905373101200_R1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.lpm.2018.08.014","article-title":"Familial Mediterranean fever","volume":"48","author":"Ozdogan","year":"2019","journal-title":"Press Medicale"},{"key":"2022010905373101200_R2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000152370.84628.0c","article-title":"Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study","volume":"84","author":"Tunca","year":"2005","journal-title":"Medicine"},{"key":"2022010905373101200_R3","first-page":"1","article-title":"About colchicine compliance, resistance and virulence","volume":"27","author":"Ben-Chetrit","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"2022010905373101200_R4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.semarthrit.2017.03.006","article-title":"Colchicine resistance and intolerance in familial Mediterranean fever: definition, causes, and alternative treatments","volume":"47","author":"Ozen","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"2022010905373101200_R5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/S0049-0172(03)00137-9","article-title":"Colchicine nonresponsiveness in familial mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization","volume":"33","author":"Lidar","year":"2004","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"2022010905373101200_R6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3899\/jrheum.100718","article-title":"Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine","volume":"38","author":"\u00d6zen","year":"2011","journal-title":"J Rheumatol"},{"issue":"8","key":"2022010905373101200_R7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-157-8-201210160-00003","article-title":"Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial","volume":"157","author":"Hashkes","year":"2012","journal-title":"Ann Intern Med"},{"issue":"1","key":"2022010905373101200_R8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13075-015-0765-4","article-title":"Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever","volume":"17","author":"G\u00fcl","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"2022010905373101200_R9","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.3109\/0886022X.2015.1056064","article-title":"Association between colchicine resistance and vitamin D in familial Mediterranean fever","volume":"37","author":"Ozer","year":"2015","journal-title":"Ren Fail"},{"issue":"10","key":"2022010905373101200_R10","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00296-015-3293-2","article-title":"Treatment of colchicine-resistant familial Mediterranean fever in children and adolescents","volume":"35","author":"Eroglu","year":"2015","journal-title":"Rheumatol Int"},{"issue":"1","key":"2022010905373101200_R11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3899\/jrheum.160518","article-title":"Longterm beneficial effect of canakinumab in colchicine-resistant familial Mediterranean fever","volume":"44","author":"Laskari","year":"2017","journal-title":"J Rheumatol"},{"key":"2022010905373101200_R12","doi-asserted-by":"crossref","first-page":"7354018","DOI":"10.1155\/2016\/7354018","article-title":"Serum amyloid a level in Egyptian children with familial Mediterranean fever","volume":"2016","author":"Lofty","year":"2016","journal-title":"Int J Rheumatol"},{"issue":"4","key":"2022010905373101200_R13","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/art.39995","article-title":"Anakinra for colchicine-resistant familial Mediterranean fever: a randomized, double-blind, placebo-controlled trial","volume":"69","author":"Ben-Zvi","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"2022010905373101200_R14","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/rheumatology\/kex222","article-title":"Familial Mediterranean fever in children and adolescents: factors for colchicine dosage and predicting parameters for dose increase","volume":"56","author":"Knieper","year":"2017","journal-title":"Rheumatology"},{"issue":"1","key":"2022010905373101200_R15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00296-017-3796-0","article-title":"Familial Mediterranean fever in childhood: a single-center experience","volume":"38","author":"Barut","year":"2018","journal-title":"Rheumatol Int"},{"issue":"3","key":"2022010905373101200_R16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.semarthrit.2013.04.011","article-title":"Evidence-based recommendations for the practical management of familial Mediterranean fever","volume":"43","author":"Hentgen","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"3 Suppl 77","key":"2022010905373101200_R17","first-page":"41","article-title":"Current trends in colchicine treatment in familial Mediterranean fever","volume":"31","author":"La Regina","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"2022010905373101200_R18","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"Eular recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2022010905373101200_R19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.berh.2016.09.001","article-title":"Approach to the patients with inadequate response to colchicine in familial Mediterranean fever","volume":"30","author":"G\u00fcl","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2022010905373101200_R20","first-page":"1","article-title":"Long-term effectiveness and safety of canakinumab in pediatric familial Mediterranean fever patients","volume":"30","author":"G\u00fclez","year":"2018","journal-title":"Mod Rheumatol"},{"issue":"1","key":"2022010905373101200_R21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1586\/1744666X.2014.861325","article-title":"Anakinra for cryopyrin-associated periodic syndrome","volume":"10","author":"Kon\u00e9-Paut","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"2022010905373101200_R22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbpa.2015.12.003","article-title":"Preclinical characterization and clinical development of ILARIS(\u00ae) (canakinumab) for the treatment of autoinflammatory diseases","volume":"32","author":"Gram","year":"2016","journal-title":"Curr Opin Chem Biol"},{"issue":"5","key":"2022010905373101200_R23","first-page":"1136","article-title":"Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever","volume":"67","author":"Cazeneuve","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"4","key":"2022010905373101200_R24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/rheumatology\/ken509","article-title":"A new set of criteria for the diagnosis of familial Mediterranean fever in childhood","volume":"48","author":"Yal\u00e7inkaya","year":"2009","journal-title":"Rheumatology"},{"issue":"1","key":"2022010905373101200_R25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5455\/apr.022120120023","article-title":"Vasculitis and Orphan Disease Research in Paediatric Rheumatology (FAVOR). A glance at history and future perspectives of childhood autoinflammatory disorders","volume":"1","author":"Polat","year":"2012","journal-title":"Ann Paediatr Rheum"},{"issue":"6","key":"2022010905373101200_R26","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/annrheumdis-2015-208671","article-title":"Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF)","volume":"75","author":"Demirkaya","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022010905373101200_R27","first-page":"355","article-title":"Quality of life of patients with familial Mediterranean fever","volume":"15","author":"Buskila","year":"1997","journal-title":"Clin Exp Rheumatol."},{"issue":"1","key":"2022010905373101200_R28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-017-0609-1","article-title":"A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever","volume":"12","author":"Corsia","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"2022010905373101200_R29","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/acr.23446","article-title":"Nationwide experience with off-label use of interleukin-1 targeting treatment in familial Mediterranean fever patients","volume":"70","author":"Akar","year":"2018","journal-title":"Arthritis Care Res"},{"issue":"2","key":"2022010905373101200_R30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5152\/eurjrheum.2019.18190","article-title":"Treatment of familial Mediterranean fever with canakinumab in patients who are unresponsive to colchicine","volume":"6","author":"Berdeli","year":"2019","journal-title":"Eur J Rheumatol"},{"issue":"1","key":"2022010905373101200_R31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1590\/1516-3180.2018.0311101218","article-title":"Anti-interleukin-1 treatment among patients with familial Mediterranean fever resistant to colchicine treatment. retrospective analysis","volume":"137","author":"Sargin","year":"2019","journal-title":"Sao Paulo Med J"},{"issue":"5","key":"2022010905373101200_R32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40272-019-00354-6","article-title":"Canakinumab in children with familial Mediterranean fever: a single-center, retrospective analysis","volume":"21","author":"Kisla Ekinci","year":"2019","journal-title":"Paediatr Drugs"},{"issue":"1","key":"2022010905373101200_R33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00296-019-04366-w","article-title":"Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review","volume":"40","author":"Eren Akarcan","year":"2020","journal-title":"Rheumatol Int"},{"issue":"6 Suppl 115","key":"2022010905373101200_R34","first-page":"97","article-title":"Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?","volume":"36","author":"Erden","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2022010905373101200_R35","first-page":"S87","article-title":"Familial Mediterranean fever in small children in Turkey","volume":"29","author":"Yalcinkaya","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"2022010905373101200_R36","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s10067-016-3196-y","article-title":"Late-onset disease is associated with a mild phenotype in children with familial Mediterranean fever","volume":"35","author":"\u00d6zdel","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2022010905373101200_R37","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3906\/sag-1809-100","article-title":"The distribution of MEFV mutations in Turkish FMF patient multicenter study representing results of anatolia","volume":"49","author":"Ya\u015far Bilge","year":"2019","journal-title":"Turkish J Med Sci"},{"issue":"2","key":"2022010905373101200_R38","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/annrheumdis-2012-202774","article-title":"Increased NLRP3-dependent interleukin 1\u03b2 secretion in patients with familial Mediterranean fever: correlation with MEFV genotype","volume":"73","author":"Omenetti","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2022010905373101200_R39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.autrev.2012.07.025","article-title":"Incomplete response to colchicine in M694V homozygote FMF patients","volume":"12","author":"Lidar","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"2","key":"2022010905373101200_R40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1442-200X.2008.02554.x","article-title":"Genotype-phenotype correlation in children with familial Mediterranean fever in a Turkish population","volume":"50","author":"Du\u015funsel","year":"2008","journal-title":"Pediatr Int"},{"key":"2022010905373101200_R41","first-page":"1540","article-title":"Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever","volume":"34","author":"Tufan","year":"2007","journal-title":"J Rheumatol"},{"issue":"75","key":"2022010905373101200_R42","article-title":"Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature","volume":"10","author":"van der Hilst","year":"2016","journal-title":"Biol Targets Ther"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1080\/14397595.2021.1908502\/41822435\/1908502.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/32\/1\/177\/42083534\/1908502.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/32\/1\/177\/42083534\/1908502.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:56:13Z","timestamp":1642560973000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/32\/1\/177-185\/6469729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,4,15]]},"published-print":{"date-parts":[[2022,1,5]]}},"URL":"https:\/\/doi.org\/10.1080\/14397595.2021.1908502","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,4,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=imor20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=imor20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-12-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}